Navigation Links
China Kanghui Holdings Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting
Date:9/6/2011

CHANGZHOU, China, Sept. 6, 2011 /PRNewswire-Asia/ -- China Kanghui Holdings (NYSE: KH) ("Kanghui" or the "Company"), a leading domestic developer, manufacturer and marketer of orthopedic implants in China, today announced that all shareholder resolutions proposed at the Company's 2011 annual general meeting held in Hong Kong on September 5, 2011 were duly adopted. Specifically, the shareholders passed resolutions approving:

  1. Re-election of Mr. Yikang Jiang as a Class A director of the Company.
  2. Re-election of Mr. Jun Du as a Class A director of the Company.
  3. Re-election of Ms. Shuchun Gao as a Class A director of the Company.
  4. Appointment of Ernst & Young Hua Ming as independent auditor of the Company for the fiscal year ending December 31, 2011.
  5. Amendment of the 2010 Share Incentive Plan to increase share limit.

Pursuant to the resolutions adopted, Mr. Yikang Jiang, Mr. Jun Du and Ms. Shuchun Gao were re-elected as Class A directors of the Company for a term of three years, Ernst & Young Hua Ming was appointed as independent auditor of the Company for the fiscal year ending December 31, 2011, and the share limit of the Company's the 2010 Share Incentive Plan was increased to 15,793,708 ordinary shares, representing approximately 9.29% of the Company's total outstanding shares on a fully diluted basis as of September 5, 2011.

About China Kanghui HoldingsFounded in 1997, Kanghui is a leading domestic developer, manufacturer and marketer of orthopedic implants in China. The Company offers a wide array of proprietary orthopedic implant products in trauma and spine. It has an extensive network of distributors for its products in China. In addition, Kanghui's products are distributed in 28 countries. Kanghui has strong research and development capabilities, focused on developing new proprietary products, including new product lines, extensions of existing product lines and enhancements of existing products. For more information, please visit www.kanghui.com.Contact:China Kanghui Holdings Investor Relations Department  +1-888-321-2558Asia Bridge Capital LimitedCarene Toh+86-186 1835 6339carene.toh@asiabridgegroup.com
'/>"/>

SOURCE China Kanghui Holdings
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. China Cord Blood Corporation Announces Participation in Upcoming Investor Conferences
2. Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets
3. China Botanic Pharmaceutical Enters into Research Cooperation with Key Laboratory of Forest Plant Ecology
4. China Nuvo Solar Target Acquisition SurgLine Reports on Marketing Progress
5. China Nepstar Chain Drugstore Announces Share Repurchase Program
6. China Nepstar Chain Drugstore Reports Second Quarter 2011 Financial Results
7. China Nepstar Chain Drugstore Announces Management Change
8. China Medicine Corporation Dismisses Frazer Frost as Auditor
9. VacChina 2011 - Bridging the China Vaccine Industry with the World Class Biotechnologies
10. China Contract Research Organization (CRO) Industry Report, 2010-2011
11. Abbott Expanding Manufacturing Capacity in China to Meet Demands of Fast-Growing Nutrition Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... , Feb. 4, 2016 Summary Breast ... cancer and the most common cancer in women worldwide, ... disease exceedingly prevalent. The number of women diagnosed with ... but the number of deaths has declined due to ... treatment has been revolutionized in the past four decades, ...
(Date:2/4/2016)... VIEW, Calif., Feb. 4, 2016  Omnicell, Inc. (NASDAQ: ... management solutions to healthcare systems, today announced results for ... --> --> GAAP ... $130.3 million, up $5.1 million or 4.1% from the ... 7.2% from the fourth quarter of 2014. Revenue for ...
(Date:2/4/2016)... 4, 2016 In response to the opioid abuse ... Commissioner for Medical Products and Tobacco, along with other FDA ... agency,s approach to opioid medications. The plan will focus on ... in pain access to effective relief. ... , Re-examine the risk-benefit paradigm for opioids and ensure that ...
Breaking Medicine Technology:
(Date:2/8/2016)... Los Angeles, CA (PRWEB) , ... February 08, 2016 , ... ... autism conference held annually in this country. The AutismOne 2016 Conference, which is being ... the truth they often won’t hear elsewhere about helpful interventions and causes of chronic ...
(Date:2/7/2016)... ... February 07, 2016 , ... ... MyDecision™ empowers employers and organizations with the tools and information to lower the ... elements to cut the cost of providing employee healthcare benefits by as much ...
(Date:2/6/2016)... ... February 06, 2016 , ... With the FCPX LUT: Summer ... grades to their footage. A LUT is a Lookup Table that contains a mathematical ... color indicated by the table. By manipulating each pixel, LUT's can change each color ...
(Date:2/5/2016)... ... February 05, 2016 , ... Love is in the air at King Kullen! ... assortments and packaging. This staple for Valentine’s Day is a must-have, and can be ... Valentine’s Day, not only are long-stem roses available, but also other flower bouquets, elegantly ...
(Date:2/5/2016)... ... 2016 , ... The event is being held on April 7, 2016 from ... Triumph Over Parkinson’s will fund nearly $100,000 for research for the care and cure ... disease and is the architect of this informative event to raise awareness and funds ...
Breaking Medicine News(10 mins):